Literature DB >> 25990459

MicroRNA expression profiles in muscle-invasive bladder cancer: identification of a four-microRNA signature associated with patient survival.

Zheng Xu1, Yan-Qiu Yu2, Yu-Zheng Ge1, Jia-Geng Zhu1, Meng Zhu3, You-Cai Zhao4, Lu-Wei Xu1, Xiao-Bing Yang4, Li-Guo Geng3, Quan-Liang Dou1, Rui-Peng Jia5.   

Abstract

Bladder cancer ranks the second most common genitourinary tract cancer, and muscle-invasive bladder cancer (MIBC) accounts for approximately 25 % of all bladder cancer cases with high mortality. In the current study, with a total of 202 treatment-naïve primary MIBC patients identified from The Cancer Genome Atlas dataset, we comprehensively analyzed the genome-wide microRNA (miRNA) expression profiles in MIBC, with the aim to investigate the relationship of miRNA expression with the progression and prognosis of MIBC, and generate a miRNA signature of prognostic capabilities. In the progression-related miRNA profiles, a total of 47, 16, 3, and 84 miRNAs were selected for pathologic T, N, M, and histologic grade, respectively. Of the eight most important progression-related miRNAs, four (let-7c, mir-125b-1, mir-193a, and mir-99a) were significantly associated with survival of patients with MIBC. Finally, a four-miRNA signature was generated and proven as a promising prognostic parameter. In summary, this study identified the specific miRNAs associated with the progression and aggressiveness of MIBC and a four-miRNA signature as a promising prognostic parameter of MIBC.

Entities:  

Keywords:  Biomarker; Muscle-invasive bladder cancer; Prognosis; microRNA

Mesh:

Substances:

Year:  2015        PMID: 25990459     DOI: 10.1007/s13277-015-3559-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  41 in total

1.  Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis.

Authors:  Na Liu; Nian-Yong Chen; Rui-Xue Cui; Wen-Fei Li; Yan Li; Rong-Rong Wei; Mei-Yin Zhang; Ying Sun; Bi-Jun Huang; Mo Chen; Qing-Mei He; Ning Jiang; Lei Chen; William C S Cho; Jing-Ping Yun; Jing Zeng; Li-Zhi Liu; Li Li; Ying Guo; Hui-Yun Wang; Jun Ma
Journal:  Lancet Oncol       Date:  2012-05-03       Impact factor: 41.316

Review 2.  Epidemiology and risk factors of urothelial bladder cancer.

Authors:  Maximilian Burger; James W F Catto; Guido Dalbagni; H Barton Grossman; Harry Herr; Pierre Karakiewicz; Wassim Kassouf; Lambertus A Kiemeney; Carlo La Vecchia; Shahrokh Shariat; Yair Lotan
Journal:  Eur Urol       Date:  2012-07-25       Impact factor: 20.096

3.  MiR-193a-3p promotes the multi-chemoresistance of bladder cancer by targeting the HOXC9 gene.

Authors:  Lei Lv; Yang Li; Hui Deng; Cheng Zhang; Youguang Pu; Liting Qian; Jun Xiao; Weidong Zhao; Qi Liu; Daming Zhang; Yingwei Wang; Hongyu Zhang; Yinghua He; Jingde Zhu
Journal:  Cancer Lett       Date:  2014-11-11       Impact factor: 8.679

4.  Bladder cancer.

Authors:  Peter E Clark; Neeraj Agarwal; Matthew C Biagioli; Mario A Eisenberger; Richard E Greenberg; Harry W Herr; Brant A Inman; Deborah A Kuban; Timothy M Kuzel; Subodh M Lele; Jeff Michalski; Lance C Pagliaro; Sumanta K Pal; Anthony Patterson; Elizabeth R Plimack; Kamal S Pohar; Michael P Porter; Jerome P Richie; Wade J Sexton; William U Shipley; Eric J Small; Philippe E Spiess; Donald L Trump; Geoffrey Wile; Timothy G Wilson; Mary Dwyer; Maria Ho
Journal:  J Natl Compr Canc Netw       Date:  2013-04-01       Impact factor: 11.908

Review 5.  Extracellular vesicles shed by glioma cells: pathogenic role and clinical value.

Authors:  Dimitry A Chistiakov; Vladimir P Chekhonin
Journal:  Tumour Biol       Date:  2014-06-27

6.  Distinct microRNA alterations characterize high- and low-grade bladder cancer.

Authors:  James W F Catto; Saiful Miah; Helen C Owen; Helen Bryant; Katie Myers; Ewa Dudziec; Stéphane Larré; Marta Milo; Ishtiaq Rehman; Derek J Rosario; Erica Di Martino; Margaret A Knowles; Mark Meuth; Adrian L Harris; Freddie C Hamdy
Journal:  Cancer Res       Date:  2009-10-20       Impact factor: 12.701

7.  Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro.

Authors:  Lars Dyrskjøt; Marie S Ostenfeld; Jesper B Bramsen; Asli N Silahtaroglu; Philippe Lamy; Ramshanker Ramanathan; Niels Fristrup; Jens L Jensen; Claus L Andersen; Karsten Zieger; Sakari Kauppinen; Benedicte P Ulhøi; Jørgen Kjems; Michael Borre; Torben F Orntoft
Journal:  Cancer Res       Date:  2009-06-01       Impact factor: 12.701

8.  Tumor miR-125b predicts recurrence and survival of patients with clear-cell renal cell carcinoma after surgical resection.

Authors:  Qiang Fu; Zheng Liu; Deng Pan; Weijuan Zhang; Le Xu; Yu Zhu; Haiou Liu; Jiejie Xu
Journal:  Cancer Sci       Date:  2014-09-23       Impact factor: 6.716

9.  BRB-ArrayTools Data Archive for human cancer gene expression: a unique and efficient data sharing resource.

Authors:  Yingdong Zhao; Richard Simon
Journal:  Cancer Inform       Date:  2008-04-21

10.  miR-193a-3p regulates the multi-drug resistance of bladder cancer by targeting the LOXL4 gene and the oxidative stress pathway.

Authors:  Hui Deng; Lei Lv; Yang Li; Cheng Zhang; Fang Meng; Youguang Pu; Jun Xiao; Liting Qian; Weidong Zhao; Qi Liu; Daming Zhang; Yingwei Wang; Hongyu Zhang; Yinghua He; Jingde Zhu
Journal:  Mol Cancer       Date:  2014-10-14       Impact factor: 27.401

View more
  19 in total

1.  Comprehensive investigation of aberrant microRNA profiling in bladder cancer tissues.

Authors:  Yanping Wei; Rongquan He; Yuzhuang Wu; Binliang Gan; Peirong Wu; Xiaohui Qiu; Aihua Lan; Gang Chen; Qiuyan Wang; Xinggu Lin; Yingchun Chen; Zengnan Mo
Journal:  Tumour Biol       Date:  2016-06-28

2.  miRNA-199a-5p suppresses proliferation and invasion by directly targeting NF-κB1 in human ovarian cancer cells.

Authors:  Xiaoxiao Liu; Baofeng Yao; Zhiming Wu
Journal:  Oncol Lett       Date:  2018-07-18       Impact factor: 2.967

3.  Expression of urinary miRNAs targeting NLRs inflammasomes in bladder cancer.

Authors:  Ettore Mearini; Giulia Poli; Giovanni Cochetti; Andrea Boni; Maria Giulia Egidi; Stefano Brancorsini
Journal:  Onco Targets Ther       Date:  2017-05-22       Impact factor: 4.147

4.  A four-miRNA signature in serum as a biomarker for bladder cancer diagnosis.

Authors:  Rongkang Li; Xuan Chen; Xinji Li; Guocheng Huang; Chong Lu; Zhenyu Wen; Zebo Chen; Yongqing Lai
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

Review 5.  The role of microRNAs in bladder cancer.

Authors:  Hideki Enokida; Hirofumi Yoshino; Ryosuke Matsushita; Masayuki Nakagawa
Journal:  Investig Clin Urol       Date:  2016-06-07

6.  Repression of the miR-93-enhanced sensitivity of bladder carcinoma to chemotherapy involves the regulation of LASS2.

Authors:  Jingyu Liu; Haifeng Wang; Yan Wang; Zhenkun Li; Yi Pan; Qiying Liu; Mingying Yang; Jiansong Wang
Journal:  Onco Targets Ther       Date:  2016-03-29       Impact factor: 4.147

7.  Decreased expression of let-7c is associated with non-response of muscle-invasive bladder cancer patients to neoadjuvant chemotherapy.

Authors:  Ruth L Vinall; Clifford G Tepper; Alexandra A Z Ripoll; Regina F Gandour-Edwards; Blythe P Durbin-Johnson; Stanley A Yap; Paramita M Ghosh; Ralph W deVere White
Journal:  Genes Cancer       Date:  2016-03

Review 8.  MicroRNAs, TGF-β signaling, and the inflammatory microenvironment in cancer.

Authors:  Lingling Guo; Yongsheng Zhang; Lifeng Zhang; Fengbo Huang; Jinfan Li; Shouli Wang
Journal:  Tumour Biol       Date:  2015-11-12

9.  Meta-analysis of microRNAs as biomarkers for muscle-invasive bladder cancer.

Authors:  Lin-Feng Zheng; Wen-Yong Sun
Journal:  Biomed Rep       Date:  2016-06-23

10.  MicroRNA expression profiles predict progression and clinical outcome in lung adenocarcinoma.

Authors:  Kang Lin; Tao Xu; Bang-Shun He; Yu-Qin Pan; Hui-Ling Sun; Hong-Xin Peng; Xiu-Xiu Hu; Shu-Kui Wang
Journal:  Onco Targets Ther       Date:  2016-09-15       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.